Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.

Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB Sr, Wilson PW.

Circulation. 2004 Jul 27;110(4):380-5. Epub 2004 Jul 19.

2.

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

Ridker PM, Wilson PW, Grundy SM.

Circulation. 2004 Jun 15;109(23):2818-25. Review.

3.

C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?

Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheugt FW, Wolbink GJ, Hack CE.

Circulation. 1999 Jul 6;100(1):96-102. Review.

4.

C-reactive protein and cardiovascular disease: a review of risk prediction and interventions.

de Ferranti S, Rifai N.

Clin Chim Acta. 2002 Mar;317(1-2):1-15. Review.

PMID:
11814453
5.
6.

Pre-diabetes, insulin resistance, inflammation and CVD risk.

Haffner SM.

Diabetes Res Clin Pract. 2003 Jul;61 Suppl 1:S9-S18. Review.

PMID:
12880690
7.

Metabolic syndrome in blacks: are the criteria right?

Osei K.

Curr Diab Rep. 2010 Jun;10(3):199-208. doi: 10.1007/s11892-010-0116-4. Review.

PMID:
20425583
8.

C-reactive protein and cardiovascular disease: new insights from an old molecule.

Hirschfield GM, Pepys MB.

QJM. 2003 Nov;96(11):793-807. Review.

PMID:
14566035
9.

[The significance of high sensitive C reactive protein as a risk factor for cardiovascular diseases].

Meguro S, Ishibashi M, Takei I.

Rinsho Byori. 2012 Apr;60(4):356-61. Review. Japanese.

PMID:
22686046
10.

C-reactive protein and uremia.

Wanner C, Drechsler C, Krane V.

Semin Dial. 2009 Jul-Aug;22(4):438-41. doi: 10.1111/j.1525-139X.2009.00596.x. Review.

PMID:
19708997
11.

Metabolic syndrome and cardiometabolic risk factors.

Papakonstantinou E, Lambadiari V, Dimitriadis G, Zampelas A.

Curr Vasc Pharmacol. 2013 Nov;11(6):858-79. Review.

PMID:
24484465
12.

Metabolic syndrome and cardiovascular diseases in Korea.

Suh S, Lee MK.

J Atheroscler Thromb. 2014;21 Suppl 1:S31-5. Review.

13.

Dietary patterns, inflammation and the metabolic syndrome.

Ahluwalia N, Andreeva VA, Kesse-Guyot E, Hercberg S.

Diabetes Metab. 2013 Apr;39(2):99-110. doi: 10.1016/j.diabet.2012.08.007. Epub 2012 Oct 11. Review.

PMID:
23062863
14.

Human C-reactive protein and the metabolic syndrome.

Devaraj S, Singh U, Jialal I.

Curr Opin Lipidol. 2009 Jun;20(3):182-9. doi: 10.1097/MOL.0b013e32832ac03e. Review.

15.

A systematic review and meta-analyses on C-reactive protein in relation to periodontitis.

Paraskevas S, Huizinga JD, Loos BG.

J Clin Periodontol. 2008 Apr;35(4):277-90. doi: 10.1111/j.1600-051X.2007.01173.x. Epub 2008 Feb 20. Review.

PMID:
18294231
16.

Estimating cardiovascular disease risk and the metabolic syndrome: a Framingham view.

Wilson PW.

Endocrinol Metab Clin North Am. 2004 Sep;33(3):467-81, v. Review.

PMID:
15262291
17.

[Relation of hs-CRP and metabolic syndrome in epidemiological study].

Konishi M, Watanabe K, Okada K.

Nihon Rinsho. 2006 Dec 28;64 Suppl 9:530-5. Review. Japanese. No abstract available.

PMID:
17458276
18.

Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables.

Vancampfort D, Correll CU, Wampers M, Sienaert P, Mitchell AJ, De Herdt A, Probst M, Scheewe TW, De Hert M.

Psychol Med. 2014 Jul;44(10):2017-28. doi: 10.1017/S0033291713002778. Epub 2013 Nov 21. Review.

PMID:
24262678
19.

Evaluation of C-reactive protein in primary and secondary prevention.

Corrado E, Novo S.

J Investig Med. 2007 Dec;55(8):430-8. doi: 10.2310/6650.2007.00023. Review.

PMID:
18163969
20.

Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.

Devaraj S, Valleggi S, Siegel D, Jialal I.

Curr Atheroscler Rep. 2010 Mar;12(2):110-8. doi: 10.1007/s11883-010-0098-3. Review.

Supplemental Content

Support Center